These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 17680819

  • 21. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D, Sundermann R, Jackson R, Bastani A.
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [Abstract] [Full Text] [Related]

  • 22. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

  • 23. How the brain anticipates an attack: a study of neurophysiological periodicity in migraine.
    Siniatchkin M, Gerber WD, Kropp P, Vein A.
    Funct Neurol; 1999 Mar; 14(2):69-77. PubMed ID: 10399619
    [Abstract] [Full Text] [Related]

  • 24. Selective beta 1-adrenoceptor blockade and muscle thermogenesis.
    Fagher B, Monti M, Thulin T.
    Acta Med Scand; 1988 Mar; 223(2):139-45. PubMed ID: 2894749
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
    Dahlöf CG, Hauge AW, Olesen J.
    Cephalalgia; 2009 Nov; 29 Suppl 2():7-16. PubMed ID: 19723121
    [Abstract] [Full Text] [Related]

  • 26. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study.
    Diener HC, Hartung E, Chrubasik J, Evers S, Schoenen J, Eikermann A, Latta G, Hauke W, Study Group.
    Cephalalgia; 2001 Mar; 21(2):120-8. PubMed ID: 11422094
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of functional sympathicotonic circulatory regulation disorders with metoprolol in depot form. Cross-over double-blind study with diazepam and Beloc-Duriles].
    Hanak T.
    Med Welt; 1983 Jun 24; 34(25-26):742-7. PubMed ID: 6136891
    [No Abstract] [Full Text] [Related]

  • 28. Effects of rizatriptan on the contingent negative variation in healthy women.
    Zank R, Strehl U, Larbig W, Kotchoubey B.
    Cephalalgia; 2008 Sep 24; 28(9):922-32. PubMed ID: 18513259
    [Abstract] [Full Text] [Related]

  • 29. Effects of pregnancy on slow cortical potentials in migraine patients and healthy controls.
    Darabaneanu S, Kropp P, Niederberger U, Strenge H, Gerber WD.
    Cephalalgia; 2008 Oct 24; 28(10):1053-60. PubMed ID: 18624798
    [Abstract] [Full Text] [Related]

  • 30. Longitudinal assessment of response preparation and evaluation in migraine gives evidence for deviant maturation.
    Oelkers-Ax R, Schmidt K, Bender S, Reimer I, Möhler E, Knauss E, Resch F, Weisbrod M.
    Cephalalgia; 2008 Mar 24; 28(3):237-49. PubMed ID: 18254894
    [Abstract] [Full Text] [Related]

  • 31. [Effects of acupuncture preventive treatment on the quality of life in patients of no-aura migraine].
    Zhang Y, Zhang L, Li B, Wang LP.
    Zhongguo Zhen Jiu; 2009 Jun 24; 29(6):431-5. PubMed ID: 19563186
    [Abstract] [Full Text] [Related]

  • 32. Impact of oral dexamethasone versus placebo after ED treatment of migraine with phenothiazines on the rate of recurrent headache: a randomised controlled trial.
    Kelly AM, Kerr D, Clooney M.
    Emerg Med J; 2008 Jan 24; 25(1):26-9. PubMed ID: 18156535
    [Abstract] [Full Text] [Related]

  • 33. Neurophysiological reactivity before a migraine attack.
    Siniatchkin M, Averkina N, Andrasik F, Stephani U, Gerber WD.
    Neurosci Lett; 2006 May 29; 400(1-2):121-4. PubMed ID: 16540242
    [Abstract] [Full Text] [Related]

  • 34. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.
    MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A.
    Neurology; 2006 Dec 26; 67(12):2159-63. PubMed ID: 17190936
    [Abstract] [Full Text] [Related]

  • 35. Traditional acupuncture in migraine: a controlled, randomized study.
    Facco E, Liguori A, Petti F, Zanette G, Coluzzi F, De Nardin M, Mattia C.
    Headache; 2008 Mar 26; 48(3):398-407. PubMed ID: 17868354
    [Abstract] [Full Text] [Related]

  • 36. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Freitag F, Taylor FR, Hamid MA, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F.
    Headache; 2008 Mar 26; 48(3):368-77. PubMed ID: 18047500
    [Abstract] [Full Text] [Related]

  • 37. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P.
    Headache; 2008 Feb 26; 48(2):248-58. PubMed ID: 18234046
    [Abstract] [Full Text] [Related]

  • 38. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S, Marziniak M, Frese A, Gralow I.
    Cephalalgia; 2009 Apr 26; 29(4):436-44. PubMed ID: 19170687
    [Abstract] [Full Text] [Related]

  • 39. Contingent negative variation and efficacy of beta-blocking agents in migraine.
    Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M.
    Cephalalgia; 1986 Dec 26; 6(4):229-33. PubMed ID: 2879628
    [Abstract] [Full Text] [Related]

  • 40. Comparison of contingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan.
    Göbel H, Krapat S, Ensink FB, Soyka D.
    Headache; 1993 Dec 26; 33(10):570-2. PubMed ID: 8294198
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.